Addition of Rituximab to First-Line Treatment of Burkitt Lymphoma in Children and Young Adults in Tanzania: A Cost-Utility Analysis

Liz Morrell, William F. Mawalla, Malale Tungu, Jingjing Jiang, Lulu Chirande, Anna Schuh, George M. Ruhago, Sarah Wordsworth, Unknown, Caroline Achola, Pamela Atim, Adam Burns, Clara Chamba, Faraja Chiwanga, Anthony Cutts, Helene Dreau, Claire El Mouden, Edrick M. Elias, Philomena Goodluck, Oliver Henke, Kieran Howard, Daisy Jennings, Emmanuel Josephat, Atukuzwe Kahakwa, Hadija Kaliisa, Jacqueline Kamanga, Ismail D. Legason, Mihaela Leonte, Laura Lopez Pascua, Erick Magorosa, Salama Mahawi, Priscus Mapendo, Sam M. Mbulaiteye, Daniel Mbwambo, Elifuraha Mkwizu, Leah Mnango, Alex Mremi, Hadija Mwamtemi, Liberata Mwita, Martin D. Ogwang, Isaac Otim, Kate Ridout, George Ruhago, Godlove Sandi, Raphael Sangeda, Patricia Scanlan, Kristin Schroeder, Anna Schuh, Rehema Shungu, Paul S. Ntemi, Dimitris Vavoulis

Open source

DOI: 10.1200/go-25-00752
Published: 2026-09
Container: JCO Global Oncology
Publisher: American Society of Clinical Oncology (ASCO)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1200/go-25-00752,
  title = {Addition of Rituximab to First-Line Treatment of Burkitt Lymphoma in Children and Young Adults in Tanzania: A Cost-Utility Analysis},
  author = {Liz Morrell and William F. Mawalla and Malale Tungu and Jingjing Jiang and Lulu Chirande and Anna Schuh and George M. Ruhago and Sarah Wordsworth and Unknown and Caroline Achola and Pamela Atim and Adam Burns and Clara Chamba and Faraja Chiwanga and Anthony Cutts and Helene Dreau and Claire El Mouden and Edrick M. Elias and Philomena Goodluck and Oliver Henke and Kieran Howard and Daisy Jennings and Emmanuel Josephat and Atukuzwe Kahakwa and Hadija Kaliisa and Jacqueline Kamanga and Ismail D. Legason and Mihaela Leonte and Laura Lopez Pascua and Erick Magorosa and Salama Mahawi and Priscus Mapendo and Sam M. Mbulaiteye and Daniel Mbwambo and Elifuraha Mkwizu and Leah Mnango and Alex Mremi and Hadija Mwamtemi and Liberata Mwita and Martin D. Ogwang and Isaac Otim and Kate Ridout and George Ruhago and Godlove Sandi and Raphael Sangeda and Patricia Scanlan and Kristin Schroeder and Anna Schuh and Rehema Shungu and Paul S. Ntemi and Dimitris Vavoulis},
  year = {2026},
  journal = {JCO Global Oncology},
  doi = {10.1200/go-25-00752},
  url = {https://doi.org/10.1200/go-25-00752}
}

RIS

TY  - JOUR
TI  - Addition of Rituximab to First-Line Treatment of Burkitt Lymphoma in Children and Young Adults in Tanzania: A Cost-Utility Analysis
AU  - Liz Morrell
AU  - William F. Mawalla
AU  - Malale Tungu
AU  - Jingjing Jiang
AU  - Lulu Chirande
AU  - Anna Schuh
AU  - George M. Ruhago
AU  - Sarah Wordsworth
AU  - Unknown
AU  - Caroline Achola
AU  - Pamela Atim
AU  - Adam Burns
AU  - Clara Chamba
AU  - Faraja Chiwanga
AU  - Anthony Cutts
AU  - Helene Dreau
AU  - Claire El Mouden
AU  - Edrick M. Elias
AU  - Philomena Goodluck
AU  - Oliver Henke
AU  - Kieran Howard
AU  - Daisy Jennings
AU  - Emmanuel Josephat
AU  - Atukuzwe Kahakwa
AU  - Hadija Kaliisa
AU  - Jacqueline Kamanga
AU  - Ismail D. Legason
AU  - Mihaela Leonte
AU  - Laura Lopez Pascua
AU  - Erick Magorosa
AU  - Salama Mahawi
AU  - Priscus Mapendo
AU  - Sam M. Mbulaiteye
AU  - Daniel Mbwambo
AU  - Elifuraha Mkwizu
AU  - Leah Mnango
AU  - Alex Mremi
AU  - Hadija Mwamtemi
AU  - Liberata Mwita
AU  - Martin D. Ogwang
AU  - Isaac Otim
AU  - Kate Ridout
AU  - George Ruhago
AU  - Godlove Sandi
AU  - Raphael Sangeda
AU  - Patricia Scanlan
AU  - Kristin Schroeder
AU  - Anna Schuh
AU  - Rehema Shungu
AU  - Paul S. Ntemi
AU  - Dimitris Vavoulis
PY  - 2026
JO  - JCO Global Oncology
DO  - 10.1200/go-25-00752
UR  - https://doi.org/10.1200/go-25-00752
ER  -

APA

Morrell, L., Mawalla, W. F., Tungu, M., Jiang, J., Chirande, L., Schuh, A., Ruhago, G. M., Wordsworth, S., Unknown, Achola, C., Atim, P., Burns, A., Chamba, C., Chiwanga, F., Cutts, A., Dreau, H., Mouden, C. E., Elias, E. M., Goodluck, P., Henke, O., Howard, K., Jennings, D., Josephat, E., Kahakwa, A., Kaliisa, H., Kamanga, J., Legason, I. D., Leonte, M., Pascua, L. L., Magorosa, E., Mahawi, S., Mapendo, P., Mbulaiteye, S. M., Mbwambo, D., Mkwizu, E., Mnango, L., Mremi, A., Mwamtemi, H., Mwita, L., Ogwang, M. D., Otim, I., Ridout, K., Ruhago, G., Sandi, G., Sangeda, R., Scanlan, P., Schroeder, K., Schuh, A., Shungu, R., Ntemi, P. S., & Vavoulis, D. (2026). Addition of Rituximab to First-Line Treatment of Burkitt Lymphoma in Children and Young Adults in Tanzania: A Cost-Utility Analysis. JCO Global Oncology. https://doi.org/10.1200/go-25-00752

Source records

crossref · retrieved 2026-09-26T19:12:19.770Z